Among these predicted targets, SRCIN1 possesses tumor-suppressive properties in breast cancer and lung cancer inhibiting cell migration and proliferation (Dong et al., 2020; Guo et al., 2019). This evidence concerns the gene SRCIN1 and breast cancer.